Principal Financial Group »

Peregrine Pharmaceuticals shares owned by Principal Financial Group

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Principal Financial Group from 13F filings

Historical chart of Principal Financial Group investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Principal Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Principal Financial Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $112k 17k 6.50
2023-09-30 $3.2M 343k 9.44
2023-06-30 $5.0M 361k 13.97
2023-03-31 $7.3M 388k 18.76
2022-12-31 $5.5M 398k 13.77
2022-09-30 $7.3M 383k 19.12
2022-06-30 $5.9M 387k 15.30
2022-03-31 $9.3M 456k 20.37
2021-12-31 $14M 473k 29.18
2021-09-30 $1.9M 87k 21.57
2021-06-30 $2.2M 86k 25.65
2021-03-31 $223k 12k 18.26
2020-12-31 $153k 13k 11.53